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 Type II diabetes was identified as a major cause of adult-onset blindness. Patients 
with diabetes are at increased risk of developing corneal complications due to abrasions, 
lesions, and ulcers, because of an altered wound healing. Several surgical treatment 
modalities can correct the complications mentioned above, including corneal transplant. 
However, due to impaired wound healing displayed by diabetic tissue, surgical options 
come with an increased risk of complication. Purinoreceptors P2X7 and P2Y2 have been 
implicated in cell-cell communication, migration, cytoskeletal actin rearrangement. All of 
these are required for wound healing. Previous studies utilized irreversible inhibitors and 
siRNAs to block these purinoreceptors and showed that both cell movement and wound 
healing were affected to a significant degree. This thesis will attempt to determine the 
impact of inhibiting P2X7 and P2Y2 with their respective competitive inhibitors on cell 
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 Type 2 Diabetes Overview 
Type 2 Diabetes or Diabetes mellitus is a widespread disease that established 
itself as a significant public health crisis. According to the Center for Disease Control and 
Prevention, about one in ten Americans is currently diagnosed with diabetes 
(approximately 34 million people), and 90-95% of them have type 2 diabetes (CDC Press 
release, 2021). Current estimates predict that more than 438 million people worldwide 
will have Type 2 diabetes by 2030 (International Diabetes Federation, 2021). If CDC's 
projection holds true, this recent increase in new cases coupled with diabetes patients 
living longer projects that by 2050, one-third of the United States adult population will 
have diabetes (CDC Press release, 2021). 
Another worrisome aspect of Type 2 diabetes is its ocular complications, such as 
diabetic neurotrophic keratopathy, diabetic cataract, dry eye, and diabetic retinopathy, 
which may lead to severe vision deficits and is considered a significant cause of blindness 
among working-age people (WHO, 2018). Diabetic keratopathy is characterized by 
impaired innervation of the cornea. It leads to the decreased sensitivity of the tissue. 
These patients have a higher predisposition to impaired corneal epithelial barrier 
function, which places their ocular surface at risk for delayed wound healing. 
Unfortunately, this remains an issue, as evidenced by numerous studies in 2020 on 
patients with type 2 diabetes presenting with neurotrophic keratopathy (Wang et al., 
2020). Loss of eyesight is a troubling reality for people with this disease, and several 




Refractive surgeries such as LASIK and corneal transplantation can be an option 
to correct corneal abnormalities. However, the use of any surgical procedure in patients 
with Type 2 diabetes is complicated by an impaired wound healing displayed by patients 
with this disease. One study found that surgical procedures are a risk factor for patients 
with diabetes. Of the 202 eyes (129 diabetic patients) that underwent vitrectomy, about 
50% developed corneal complications after surgery (Hiraoka et al., 2001). Another 
potential contributor to corneal tissue instability in patients with diabetes is a reduction in 
hemidesmosomes, which are small stud-like structures uniformly distributed in the 
corneal epithelium's basal cell membrane that attach to the underlying basement 
membrane (BM) (Torricelli et al., 2013). Reduced hemidesmosomes and decreased 
penetration of anchoring fibrils could explain why the basement membrane of diabetic 
patients easily peels off from the corneal stroma, and it factors into the reduced healing 
capacity of the tissue (Tabatabay et al. 1988). 
There are multiple focal points when it comes to the pathophysiology of diabetes 
and the resultant ocular complications. This thesis will provide an overview of corneal 
structure and corneal healing mechanisms currently known to be affected by this disease's 
etiology. 
Corneal Structure and Corneal Epithelium 
The cornea is a transparent, avascular, and heavily innervated tissue covering the 
eye's front outermost portion. The cornea refracts seventy percent of the light before it 
passes through the lens. This refraction helps the light focus on the retina with minimal 




components. The major cellular components are epithelial cells, endothelial cells, and 
keratocytes. However, the cornea is also one of the most highly innervated tissues, and 
damage to the sensory nerves explains the overwhelming pain in several etiologies 
(Kneer et al., 2018). The major acellular components are glycosaminoglycans and 
collagen. Corneal cells have multiple origins, where epithelial cells are derived from 
epidermal ectoderm keratocytes, and endothelial cells are derived from the neural crest 
(Sridhar 2018). 
 





ILLUSTRATION 1: Layers of the cornea. (a) The anterior position of the cornea, 
which leaves it exposed to the outside environment. (b)The cornea is a layered 
structure that is comprised out of five layers: the epithelium, Bowman's layer, the 
stroma, Descemet's membrane, and the endothelium. (c) Corneal apical epithelium 
and (d) basal epithelium stained with rhodamine-conjugated phalloidin and DAPI, 
made on Zeiss 700 LSM (Dr. Trinkaus-Randall). Schematics on the left adapted 
from Foster, 2003. 
 
The corneal epithelium is a uniform, layered structure with approximately 5 to 7 
layers of cells. Its smooth regular surface is composed of nonkeratinized stratified 
squamous epithelium, which is derived from surface ectoderm. Epithelium layers are 
composed of superficial cells, wing cells, and basal cells. Basal cells are the only corneal 
cells capable of mitosis and are a source of wing cells and superficial cells. Superficial 




through tight junctions. These structures are made of a large complex that maintains a 
force to keep apical-basal polarity, discussed later. They prevent the entry of viruses, 
bacteria, and growth factors, thus maintaining homeostatic control. The tight junctions 
break during desquamation that balances the proliferation of the basal cells. Breakage 
also disrupts the underlying adherens junctions.  
It is worth noting that the epithelial cells' subdivision into superficial (apical) 
epithelial cells and deep basal cells follows the fundamental principles of cell polarity. 
Wing cells are typically elongated and attach to the neighboring cells using anchoring 
protein cadherin via adherens junctions. Desmosomes are also present and are associated 
by intermediate-based filaments, with the transmembrane proteins being distinct but in 
the same family as cadherins. Much communication between cells occurs between gap 
junctions, although the wound-induced Ca2+ wave is gap junction independent. Basal 
cells have a higher uniformity and are described as columnar when compared to the 
apical cells. The basal cells are the only cells that mitose. Usually, cells are differentiated 
according to which extreme they fall into, apical cells as flat and wide, whereas basal 
cells are tall and narrow. 
The junctional complex of corneal epithelial cells is composed of tight junctions 
located most apically in the apical epithelial cells' lateral walls and adherens junctions 
present underneath and more basally along the apical cells' lateral membranes. Tight 
junctions serve as a permeability barrier between cells, and maintain tension through their 
actin network. The adherens junctions and desmosomes play the greatest role in 






ILLUSTRATION 2: Apical and basal polarity. The image obtained from Alberts et 
al., 2002. 
Polarity proteins such as The Crumbs complex, Par complex, scribble complex, 
and zona occludens 1 (ZO-1), through their interactions, define the cell's end polarity. 
The Crumbs complex is responsible for the differentiation of the apical membrane. Crb3, 
also known as Crumbs-3, is a protein from The Crumbs complex that associates with the 
Par complex is upstream from protein kinase C (PKC) and activates it. Activated Protein 
Kinase C or aPKC phosphorylates a critical molecular switch that is featured heavily 
throughout the healing pathways, known as Ras-related botulinum toxin substrate one or 
Rac1. Rac1, a G protein following its activation, is essential for the formation of tight 




differentiation of the basolateral membrane.
 
ILLUSTRATION 3: Polarity proteins which define the end polarity of the corneal 
epithelium. Adapted from Anne Londregan Thesis, 2018. 
Cell morphology is influenced by the specific concentrations of the particular 
protein. For example, if the basal cell was to have an increased concentration of the 
scribble protein complex, it may increase the overall number of tight junctions. This 
process will effectively transform this cell from its original morphology into an apical 
cell. This process is often observed during epithelial wound healing of the corneal cells 
and is accompanied by the increased expression of Rac1. 
On the other hand, the basal cells are attached to the underlying basement 
membrane by hemidesmosomes. This form of strong attachment is necessary to maintain 




present with corneal epithelium abnormalities that progress to corneal erosion, persistent 
corneal defects, or corneal ulcers (Jeganathan, Wang, & Wong, 2008).  
 
ILLUSTRATION 4: Junctional Complexes. Adapted from Sridhar, 2018. 
The cornea's dual role of being a transparent tissue that allows light to pass 
towards the retina and its ability to act as a mechanical barrier between the external 
environment and the eye's inner contents leaves it exposed to various potential pathogens, 
toxins, and mechanical injuries from the debris. Therefore, corneal healing is a complex 
process that involves multiple layers of this tissue, and any existing pathology, such as 
diabetes, can detrimentally affect it. 
Corneal transparency is maintained by a complex mechanism of interaction 
between the epithelium and endothelium of the corneal tissue, which also serves as a 
mechanical barrier to fluid diffusion and creates an osmotic gradient that pushes the 




hexagonal shape and form a monolayer which acts as a barrier between the corneal 
stroma and aqueous humor (Bahn, 1984). CECs also have pump functions and are 
involved in regulating stromal hydration. It is the problem with the pump function that 
leads to Fuch’s disease. In humans, they display a limited proliferative ability. Their loss, 
usually from a form of a mechanical injury, age or ocular surgery, leads to the 
compromise of the corneal endothelium and a subsequent opacification of the cornea. 
This eventuality may necessitate a transplant of either a whole cornea segment or with the 
modern development of newer forms of lamellar transplantation only of the affected 
layers (Tan, 2012).  
Descemet's membrane separates CECs from the stroma. It is composed mainly of 
collagen Type IV collagen and other matrix proteins including fibronectin and perlecan. 
It provides a stable scaffold during morphogenesis (Wulle, 1969). It was noted that 
Descemet's membrane has a critical role in CEC regeneration following an injury (Chen 
et al., 2017). 
Corneal Wound Healing and Growth Factors 
Corneal wound healing is a complicated process that revolves around a multitude 
of separate processes that operate in conjunction. It involves cell death, migration, 
proliferation, differentiation, and extracellular matrix remodeling (Ljubimov et al., 2015). 
Each cellular layer (corneal epithelial, stromal, and basal endothelial layer) has both 
similar and differing mechanisms of dealing with an injury. For example, corneal 




membrane (BM). Whereas in the case with stromal cells, usually immobile keratocytes 
transform into fibroblasts and myofibroblasts following the activation by transforming 
growth factor-β and deposit a matrix while they remodel the stroma. Endothelial cells 
follow a pattern of migration and spreading.  
Definitive similarities in the healing processes between cell groups, such as cell 
migration, the necessity of growth factors, and remodeling of the extracellular matrix, are 
overshadowed by exhibited differences in healing in between cell types. Epithelial cells 
rely on the limbal stem cells and undergo frequent movement and differentiation. This 
reliance is in contrast to the endothelium, where cells mostly heal by migration and 
spreading. Endothelial cells can also undergo epithelial to mesenchymal transformation. 
As was mentioned above, stromal cells heal through a sequence where stromal 
keratocytes transform into fibroblasts and myofibroblasts under the influence of resident 
and circulating immune cells (Ljubimov et al., 2015) (Fig 5.). Following an injury to the 
eye, numerous growth factors are released. One potential source is the tear film, a 






ILLUSTRATION 5: Growth factors (Ljubimov et al., 2015). 
Growth factors in conjunction with cytokines stimulate growth, proliferation, 
migration, differentiation, adhesion, extracellular matrix deposition during wound healing 
(Ljubimov et al., 2015). Specific cells can respond to many growth factors and cytokines. 
Epidermal growth factor (EGF) initiates cell migration and proliferation (Zieske et al., 
2000; Lu et al., 2001; Nakamura et al., 2001). It is stimulated when Epidermal Growth 
Factor Receptor (EGFR) belonging to the class of tyrosine kinase receptors becomes 
activated during injury, which turns on a multitude of downstream effectors such as 
phosphatidylinositol-3-kinase (PI3-kinase)-Akt axis and extracellular regulated kinase 
(ERK) (Wang et al., 2012).  PI3-kinase-Akt pathway and altered EGFR signaling 
disruption observed during in vivo studies in rats with diabetes resulted in decreased 
ability to heal the corneal epithelium wounds (Xu et al., 2011). EGFR stimulation 
performed by inhibition of its negative regulator E3 ubiquitin ligase (c-CbI) has increased 
the healing rate in the corneal epithelial layer and was observed both in vitro and in vivo 





ILLUSTRATION 6: PI3-kinase/Akt pathway is responsible for increased 
metabolism, proliferation, and cell growth (Hemmings et al., 2012).  
 
ILLUSTRATION 7: ERK pathway, also known as the MAPK pathway, is 
responsible for promoting mammalian cell growth and proliferation upon activation 





EGFR signaling also activates nuclear factor kappa-light-chain-enhancer of 
activated B cells pathway (NF-kB), leading to activation of a transcriptional repressor 
CTCF and downregulation of PAX6. This mechanism results in cell migration and 
proliferation of CECs (Imanishi et al., 2000). NF-kB's role in epithelial wound healing 
was confirmed via the use of NF-kB p50 knockout mice, who exhibit a significantly 
delayed wound healing (Wang et al., 2013). 
 Another notable ligand of EGFR, transcription growth factor-alpha (TGF-
α) which, upon binding to the receptor, facilitates corneal epithelial migration and 
proliferation similarly to EGF (Ljubimov et al., 2015). Mice that genetically lack TGF-α 
production display chronic corneal erosions (Mann et al., 1993). It is also worth noting 
that TGF-α was empirically determined through in vitro study to be a more potent 
activator of EGFR mediated corneal wound healing when compared to EGF. This finding 
was linked to its ability to stimulate EGFR endocytosis and subsequently recycle the 
receptor back to the membrane's surface, which allows further stimulation of the receptor 
(McClintock et al., 2010). 
Hepatocyte growth factor (HGF) or scatter factor is produced by mesenchymal 
cells and targets epithelial cells through their surface receptor c-met (Rosen et al., 1994). 
HGF, via its interaction with c-met, a proto-oncogene, is responsible for regulating CECs 
cell proliferation, migration, and apoptosis (Ljubimov et al., 2015). HGF activates c-met 
by phosphorylation of the latter. Activated c-met sends a downstream signal and, in turn, 




mainly localized to the central cornea. On the other hand, their mRNAs can be found in 
all major cell types of the cornea: epithelial, stromal, and endothelial cells (Wilson et al., 
1993). If the corneal epithelium is wounded, HGF production is upregulated in both 
keratocytes and epithelial cells (Li et al., 1996). This response probably serves to 
facilitate the healing of the tissue. Diabetic corneas feature decreased expression of HGF 
and c-met proto-oncogene and impaired wound healing. Upon restoring decreased levels 
of c-met in diabetic corneas with the use of gene-therapy, normalization of wound 
healing was observed (Saghizadeh et al., 2010).  
Keratinocyte Growth Factor (KGF), mainly expressed by the lacrimal gland and 
limbal fibroblasts. It is present in the tear film and increases corneal wound healing in 
rabbit corneas and functions similarly to HGF (Wilson et al., 1998). KGF acts through 
ERK/MAPK pathway and PI3K/p70 signaling cascades in CECs to promote healing 
(Chandrasekher et al., 2001; Sharma et al., 2003). 
Insulin-like growth factors (IGFs) enhance cell proliferation, regulate migration 
and survival of CECs (Ljubimov et al., 2015). IGF receptors are expressed at an 
increased rate in wounded mouse corneas, shown by in vivo studies. The overexpression 
of the receptor resulted in increased limbal cell differentiation into corneal cells but did 
not affect limbal cell proliferation (Trosan et al., 2012). Limbal cells are located in the 
limbus's basal layer and are responsible for corneal epithelial healing following an injury. 
Upon injury, they could be viewed as a repository of cells and undergo differentiation 




Transforming growth factor-β and its isoforms (TGF-β1, TGF-β2, and TGF-β3), 
as well as its receptors, are found in corneal epithelium and stromal keratocytes (Nishida 
et al., 1994). TGF-β can stimulate corneal epithelial migration via ERK/MAPK pathway 
activation. It is also implicated in ECM remodeling (Bhowmick et al., 2001) and 
epithelial to mesenchymal transformation (EMT) (Saika et al., 2004), which leads to 
increased cellular motility. 
Multiple other growth factors affect wound healing, namely thymosin-β4 (Tβ4), 
interleukins 6 and 10 (IL-6 and IL-10), nerve growth factor (NGF), and opioid growth 
factor (OGF). 
Following an injury (Fig 8), two types of epithelial movement were observed 
during visualization of the rat's corneal epithelium. At first, an initial sliding and ruffling 
of the monolayer of epithelial cells occurs, characterized as the sheet-like movement. 
Each epithelial cell at the leading edge of the wound starts to change its shape and 
become elongated while maintaining its tight junctions with neighboring cells. This 
transformation allows a cell to cover a wide area with the use of fan-shaped lamellipodia. 
The denuded area is then covered by these migrating cells. A transient ECM is deposited 
by epithelial cells and may contain several types of proteins such as fibrin, fibronectin, 
and hyaluronic acid. These proteins facilitate the wound's closure by acting as a 
temporary matrix for the sheet of the epithelium to migrate along (Bukowiecki et al., 
2017). While the cells move en masse, they maintain cell-cell adhesions. All of the cells 




aspect (Stepp et al., 2014). Once the wound closure occurs, the basal cells proliferate if 
the wound is large. The cells then differentiate and restore the multi-layered morphology. 
The hemidesmosomes that were degraded under the migrating cells are reassembled 
under stationary cells, and the anchoring of the α6β4-integrin binds to cytoplasmic and 
extracellular components. As the hemidesmosomes are degraded, there is a correlative 
decrease in protein expression in this complex and an increase in proteins in the focal 












ILLUSTRATION 8: Wound healing progress and planar polarity. Note that intact 
epithelium still maintains its apical/basal polarity. After wounding, cells continue 
along the wound's leading edge, which creates a planar polarity (wound edge and 







Purinergic receptors P2X and P2Y 
A signal that elicits ubiquitous response throughout the corneal tissue is the 
nucleotide, ATP (Lee et al., 2019). ATP is probably released when a cell undergoes a 
change in shape, which is observed in bronchial epithelial (Barrios., 2017) and also 
during corneal epithelial injury (Klepeis et al., 2001). ATP binds to purinoreceptors, 
which triggers a transient Ca2+ wave, used by the cells to translate mechanical signals 
into chemical ones, further altering downstream pathways (Boucher et al., 2007). The 
resultant Ca2+ wave propagates to the other cells. ATP was identified by taking the cell 
medium and transferring it to unwounded cultures in the presence or absence of apyrase, 
where it generated a similar Ca2+ wave. When the resultant media was pretreated with 
apyrase, a highly active ATP-diphosphorylase, there was no resultant Ca2+ wave 
(Klepeis et al., 2004). This enzyme causes sequential hydrolysis of ATP to ADP to AMP 
and degrading all available ATP. Nucleotides participate in protein phosphorylation of 
EGFR, ERK, Src, ß4 integrin, and paxillin (Boucher et al., 2007; Kehasse et al., 2013; 
Minns et al., 2016). Knockdown of P2Y2 G-protein receptor resulted in decreased Ca2+ 
mobilization, wound healing, and phosphorylation of paxillin and EGFR (Kehasse et al., 
2013).  
Purinergic receptors utilize nucleotides as ligands, and two distinct classes of 
those receptors were examined in this thesis and the effects of their inhibition on cellular 
motility. P2Y receptor, a G-protein coupled receptor (GPCRs), and P2X receptor, which 




proliferation, and inflammation (Abbracchio et al., 2009). Currently, there are eight 
distinct subtypes of P2Y receptors (P2Y1, P2Y2, etc.) (Burnstock, 2007). Corneal 
epithelial cells express P2Y1, 2, 4, 6, and 11 receptor subtypes (Klepeis et al., 2004; 
Mankus et al., 2011).  
When a P2Y receptor is activated, it results in the heterotrimeric G-proteins' 
recruitment, which affects the PKC/ERK/MAPK pathway, PKC/Src pathway, and 
inducing Ca2+ release from intracellular stores (Fig 9). P2Y receptors are also capable of 
directly affecting intracellular signaling proteins, which affect wound repair and cell 
migration (Klepeis et al., 2004). P2X7, a subtype of P2X ligand-gated ion channel 
receptor, is significantly elevated in the diabetic cornea (Mankus et al.,2011). In a healthy 
corneal epithelium, it is prominent along the leading edge of the wound, which is 
correlated to its potential involvement in the wound healing process and its role as a 
sensor (Minns et al., 2011). A feed-forward system exists in a place, which moves ATP 
through pannexin channels to activate P2X7 receptors. This system provides a continuous 
ATP supply to be released along the wound margin (Boudreault and Grygorczyk 2004). 
The leading edge (LE) is defined as the first three rows of cells adjacent to the wound 
itself, and cells that are further away (five rows or more) are considered back from the 
leading edge (BFLE). Increased P2X7R localization at the LE suggests that these cells 
upregulate P2X7R and facilitate Ca2+ wave that enables migration of the cells due to an 




shown a marked decrease in cell migration and cancels P2X7 injury-induced change in 
localization (Minns et al., 2016). 
When Ca2+ enters the cell and increases the intracellular concentration, it 
activates the cell migration pathway. The cell starts to restructure its actin skeleton 
components and begins to move in the direction of higher ATP concentration. After an 
initial lag phase, where the cell ramps up its protein synthesis, the cells begin to move to 
cover the lesion. The cells at the leading edge can undergo numerous changes, such as the 
dissolution of cortical actin, synthesis, and formation of stress fibers, as well as the 
creation of lamellipodia. Intercellular adhesion structures can be lost or loosened to 
facilitate cellular motility. The corneal epithelial cells migrate in a sheet-like fashion 
rather than one cell at a time. It could be possibly due to the presence of cadherin-
containing adhesion complexes, which link neighboring cells (Block et al., 2004). 
P2Y2 and P2X7 receptors are crucial in the release of Ca2+ initially after 
wounding. ATP released from wounded cells activates both of these receptors. Results 
found by Lee et al., 2019 during studies with competitive inhibitors to P2Y2 (AR-C 
118925XX) and P2X7 (A438079) showed that the probability of cell-to-cell 
communication significantly decreases when compared to uninhibited agonist control. 
This finding shows that both P2Y2 and P2X7 are implicated in Ca2+ signaling through 





ILLUSTRATION 9: P2X7 and P2Y2 
purinoreceptors. P2Y2 is a metabotropic G-
protein coupled receptor that, upon binding 
of ATP, triggers a second messenger 
cascade via G-trimeric protein, PLC-β, and 
Adenyl Cyclase (AC). This releases stored 
calcium from the cell into the surrounding 
cytoplasm. P2X7 is an ionotropic ion 
channel receptor that allows potassium to 
flow out of the cell and calcium to flow into 
the cell when ATP binds to it. Adapted from 
Björkgren & Lishko, 2016 
 
The cornea provides an excellent model to study diabetic wound repair. It is an 
avascular tissue with a high degree of innervation. Diabetic peripheral neuropathy is 
known to cause a diminished sensation, and corneal pain perception is often the first to 
become affected throughout this disease. In fact, patients with diabetes present with a 
reduced corneal nerve density compared to a healthy control population (Markoulli et al., 
2018). This finding is seen dramatically in a murine model of pre-type II diabetes (Kneer 
et al., 2018). Impairments of wound healing coupled with decreased tissue sensitivity 
have been detected in diabetic corneas (Cai et al., 2014).  
Given the implication that both P2Y2 and P2X7 have a discernable effect on 
cellular motility during the healing process, this thesis will attempt to model the impact 
of inhibiting these two proteins in HCLE cell cultures and compare it to uninhibited 








In order to investigate the effects of inhibiting P2X7 and P2Y2 on cellular mobility in 
vitro, the author will:  
(1) Maintain HCLE and diabetic cell cultures.  
(2) Perform immunohistochemistry to inhibit P2X7 or P2Y2.  
(3) Utilize confocal microscopy to produce time-lapse images of cell cultures.  
(4) Analyze images using plot profiles to plot cellular movement and construct 
cell movement diagrams.  
 
Expectations of the inhibited cells and diabetic cells, compared to control, 
include:  
(1) Abnormal movement pattern 





















 Cell culture 
 Human Corneal Limbal Epithelial (HCLE) cells were obtained from Dr. Gipson's 
lab (Harvard University, Boston, MA) and cultured in Keratinocyte Serum-Free Media 
(KSFM) with the following supplements: 25  µg/mL of bovine pituitary extract, 0.02 nM 
EGF, 0.03 mM CaCl2, 100 U/mL penicillin, 100 µg/mL streptomycin, and 0.5% 
amphotericin B.  
 Cells were maintained in 2 mL of KSFM and incubated in 35 mm glass-bottom 
culture dishes under 37 °C and 5% CO2 and grown to confluence. Approximately every 
two days, the media was replaced with a fresh one.  
 Sixteen hours before the experiment, the media was switched from KSFM to 2mL 
of Quiescent Media (Q-media), which lacked growth supplement and was made from the 
following recipe: 100 mL of Keratinocyte Serum-Free Media, 1 mL stock solution with 
100 U/mL penicillin, 100 µg/mL streptomycin and 125 mL of 0.3 M CaCl2. The cells 
were then kept in incubation until immunohistochemistry and subsequent imaging. 
 Diabetic Mouse Corneal Epithelial cells from Cell Biologics were isolated from 
the cornea of diabetic (db/db) mice at eight weeks (Cell Biologics Manual). The cells 
were incubated with Epithelial Cell Medium, Catalog No. M6621 and maintained for a 
maximum of 5-7 passages. The media was switched daily before immunohistochemistry 
staining and imaging. Diabetic Mouse Corneal Epithelial cells were not put into Q-media 





 Cells were wounded by lightly sliding a tip of a 24-gage needle over the glass 
portion of a glass-bottom culture dish. Special consideration was paid not to scratch the 
glass itself as it created an additional obstacle for the cells to migrate over and altered the 
dynamics of the wound response. 
Cell migration and Role of Purinoreceptors 
  In order to examine the role of purinoreceptors on migration, the cells were 
prepared for the experiment by removing the complete medium and replacing it with Q-
media for 16-18 hours. Prior to the experiment, the HCLE cells were washed with 2 mL 
of fresh Q-media.  
 For control conditions, HCLE cells were incubated in Spirochrome Actin (SiR-
actin), which binds to F-actin. SiR-actin is a fluorogenic, cell-permeable, and highly 
specific stain for F-actin (Spirochrome website). SiR-actin was prepared by diluting 50 
nmol SiR-actin Kit in 50 µM DMSO and then adding 1 µL of the solution to 1 mL of 
media in the glass-bottom culture dishes and pre-incubating cells for 20-30 minutes.  
 For experimental conditions, cells were incubated in the presence of P2X7 or 
P2Y2 inhibitors were added, A438079 or AR-C 118925XX (Tocris Bioscience), 
respectively, before adding SiR-actin.  
 A438079 - a competitive P2X7 inhibitor, was used at a concentration of 10 µM 
and was prepared from 100 mM aliquots. 0.2 µL of inhibitor solution in 2 mL of Q-media 




 AR-C 118925XX - a competitive P2Y2 inhibitor, was used at a concentration of 
10 µM. It was prepared from 5 mM aliquots, and 4 µL of the solution was added in 2 mL 
of Q-media before incubating for 1 hour. 
 Following the pre-incubation, the cells were washed with 2 ml of Q-media, and 
then an additional 2 mL of Q-media was added to prepare cells for imaging. 
 Diabetic Mouse Corneal Epithelial cells were stained with SiR-Actin, with an 
identical protocol used for the HCLE cells (1 µL in 1 mL of media for 30 minutes). One 
difference was that these cells were not put in Q-media, and only an Epithelial Cell 
Medium was used. Once stained, cells were put in 2 mL of Epithelial Cell Medium for 
imaging. 
Confocal Microscopy 
Cells pre-incubated with SiR Actin were imaged utilizing a Zeiss LSM 880 Laser 
Scanning Confocal Microscope with an environmental chamber (Zeiss, Thornwood, NY). 
The environmental chamber was maintained at 37°C and 5% CO2. The detailed settings 
for the microscope are displayed in Figure 10. 
Time-lapse images of the cells were obtained at 10-minute intervals for 4 hours, 
with the initial images obtained immediately after the cells' wounding with the 24-gage 
needle.  
The helium-neon laser was used for SiR Actin imaging with an excitation line at 
633 nm. The laser's power output was set at 8.5 amps, and the microscope's pinhole size 
was set to 1 Airy unit, which corresponds to an optical section of approximately 1 µm. 




For SiR-Actin movies, images were taken with a 512 by 512-pixel frame size with a pixel 
dwell time of 65.94 µs. Pixel averaging was utilized with the number option set to 1, 
mode set to frame, and method set to mean. Software-based autofocusing was found to 
increase the fidelity of the final images and was utilized before acquiring images. The 
Autofocus mode was set to definitive focus. The detector master gain was set to 600 for 
optimal brightness and contrast, but it could be modified to ± 50 to achieve optimal 
quality. Brightfield images were obtained before starting the experiment to confirm that 






FIGURE 10: Zeiss LSM 880 Settings. Note, argon laser was left "ON"; however, it 






Images were analyzed using FIJI/ImageJ (NIH, Bethesda, MD; 
http://imagej.nih.gov/ij/) and FIJI/ImageJ's Trackmate Plugin.  
Six cells per time-series were selected due to either being at the leading edge or in 
direct proximity to the leading edge. Their outlines were created using FIJI/ImageJ's 
Trackmate Plugin (Fig 11). Their coordinates from 9 sequential time stamps, which 
equates to a measurement done every 30 minutes, were uploaded to Microsoft Excel to 
create Cell Movement Diagrams.  
 
FIGURE 11: Example of cell tracking utilizing ImageJ software. A cell outline was 





The data points obtained were normalized before plotting with respect to the 
position of the wound. Positive Y-Axis was selected to represent the position of the 
wound. Cell movement diagrams were created using Microsoft Excel. Cells were placed 







 The Human Corneal Limbal Epithelial cells (HCLE) were used to simulate 
corneal wound healing in vitro.  After wounding (wound marked with a star on images), 
they were immediately placed into the environmental chamber of Zeiss LSM 880 for the 
imaging duration. 
  
FIGURE 12: Appearance of unwounded and wounded control. HCLE unwounded 
control (left) and wounded control (right), with the wound located in the upper left 
corner. Wound is marked by the star. Images were taken from separate 
experiments. Images obtained with Zeiss LSM 880.  
 
The unwounded control (Fig 12, left) demonstrates the characteristic morphology 
of HCLE cells observed throughout the experiments. They appear as highly mobile and 
large cells of uniform appearance with an extensive filamentous actin (F-actin) network 
that appear as peripheral strands surrounding a core of the nucleus (not visible). 




Diabetic cells (DB) (Fig 13) appear smaller in size than HCLE cells under the 
same magnification (63X oil). They also show a less explicit F-actin network surrounding 
the core of the nucleus. It is also worth noting the presence of globular vesicles inside the 
diabetic cells, similar in appearance to the vesicles observed in HCLE control. Diabetic 
cells displayed the highest motility in the positive y-direction out of all experimental 
conditions. 
 
FIGURE 13: Diabetic cells characteristic morphology. The wound is located in the 
upper left corner (marked with a star). Note the reduced size of individual cells 
compared with control. Images obtained with Zeiss LSM 880. 
A438079 is a competitive inhibitor of P2X7. HCLE cells were pre-incubated with 





FIGURE 14: A438079 treated HCLE cells. The wound is located in the upper right 
corner (marked with a star). Note the presence of thick actin bundles and minimal 
membrane ruffling characteristic of P2X7 inhibition (Minns et al., 2016). Image 
obtained with Zeiss LSM 880. 
A438079 treated HCLE cells (Fig 14) presented as large and mobile cells. There 
were peripheral strands of F-actin that could be visualized surrounding the core of the 
cell. A minimal amount of vesicles was noted inside the cells during imaging. 
AR-C 118925XX is a competitive inhibitor of P2Y2. HCLE cells were pre-





FIGURE 15: AR-C 118925XX treated HCLE cells. The wound in the upper right 
corner (marked with a star). Image obtained with Zeiss LSM 880. 
AR-C 118925XX treated HCLE appear similar in their morphological appearance 
to A348079 treated HCLE cells. They are large and motile cells. There is a diminished 
presence of vesicles observed inside the cells during imaging. 
 Cell Movement Diagrams 
Cell movement diagrams were constructed for each condition using Microsoft 
Excel, starting with wounded control, then A438079, AR-C 118925XX, and diabetic 
control. Wound direction was normalized across all conditions and was set to a y-positive 
direction on the x/y axis, the size of the coordinate systems was also normalized across 






FIGURE 16: Cell movement diagram of control and diabetic (DB) cell lines. Control 
(A) and Diabetic (B), wounded, cell movement diagrams, constructed with Microsoft 
Excel. Each diagram is constructed with a minimum of three experimental runs. 
From the plots, it is immediately apparent that diabetic cells have increased 
motility compared to the wounded control (Fig 16). The majority of diabetic cells move 
primarily in the y-positive direction, with a distinct subset that moved to the left of the 
wound direction. On the other hand, wounded control cells displayed a more concerted 










FIGURE 17: Cell movement diagram of all experimental conditions. Control (A), 
A438079 (B), AR-C 118925XX (C), and DB (D) wounded, cell movement diagrams 
constructed with Microsoft Excel. Each graph represents a minimum of three 
experimental runs. 
A438079 treated HCLE cells (Fig 17 B) do not appear to move in a coordinated 
fashion towards the wound (y-positive direction). Experimental observations suggest that 
they try to spread and cover a wide surface area without making a concerted effort to 
close the wound. This pattern is in stark contrast with control (Fig 17 A), where there is 
directionality in the movement to close the wound, i.e., movement in the y-positive 





direction. Movement distance is comparable to control but is still less pronounced than 
DB (Fig 16 B). 
AR-C 118925XX treated HCLE cells (Fig 17 C) appear to move in a coordinated 
fashion, but not in the direction of wound closure. Their movement is more pronounced 
when compared with control (Fig 17 A) but is still less than DB (Fig 16 B). Visually it 
















 Part of the wound healing process starts with the release of nucleotides such as 
ATP into the surrounding space following an injury (Boucher et al., 2010). Cells in the 
wounded area follow ATP concentration and begin moving toward higher extracellular 
ATP concentration, thus starting the process of sealing the lesion. Purinergic receptors, 
activated by nucleotides, have been implicated in facilitating wound healing (Boucher et 
al., 2010; Klepeis et al., 2004; Mankus et al., 2011). Two receptors of this broad family 
have been studied in this thesis. P2X and P2Y, in particular, their subclasses P2X7 and 
P2Y2, respectively. Their inhibition resulted in the disruption of the movement pattern 
following a wound to the cell culture, as shown in Fig. 17 B and C, especially when 
contrasted with control (Fig 17 A). 
P2 purinergic receptors fall into two categories. (1) The ion channel receptors 
such as P2X and (2) the G-protein coupled receptors such as P2Y (Erb et al., 2006).  
P2X receptor family and P2X7 
When extracellular ATP comes in contact with the P2X receptor family, it 
activates and opens a trimeric ion channel (Fig. 9) that gates Ca2+ and several other ions 
from the extracellular environment (Abbracchio and Burnstock, 1998). P2X7, which was 
predominantly thought of as a cell death receptor until recent discoveries implicated it in 
cell survival and growth promotion (Virgilio, Ferrari, and Adinolfi, 2009), has an 
important role in the proper epithelial cell adhesion to the basement membrane and 
maintenance of the overall integrity of corneal stroma (Mayo et al., 2008). Work done at 




receptor. It is now implicated in cell's proliferative, migratory, and death processes 
(Mankus et al., 2011). P2X7 was observed to increase its expression at the leading edge 
following an injury, while overall expression decreases further away from the wound (Fig 
18) (Minns et al., 2016).  
 
FIGURE 18: Change in P2X7 localization following an injury. Radial sections 
stained for P2X7. Leading-edge is marked with an asterisk. Note an increase of 
P2X7 expression in the immediate vicinity of the leading edge. E, epithelium; S, 
stroma in the cornea. Adapted from Minns et al., 2016. 
 
Inactivation of P2X7 was linked to decreased wound healing, evident from a 
decreased wound closure percentage (Fig 19 A). Oxidized ATP, an irreversible P2X7 
inhibitor, was utilized by Minns et al. to determine the effects of inhibiting P2X7 on the 
wound closure (Fig 19). However, this study's weakness was that the irreversible 
inhibitor could have off-target effects, which are less likely with competitive inhibitors 
such as A438079 for P2X7 and AR-C 118925XX utilized in the experiments conducted 





FIGURE 19: Inhibition of P2X7 with oxidized ATP (oxATP). Control has no 
oxATP. Leading-edge is marked with asterisks. A: control has a significantly higher 
wound closure percentage compared to oxATP, which supports the conclusion that 
P2X7 inhibition affects wound closure. B: oxATP inhibits injury-induced P2X7 
localization to the leading edge. Adapted from Minns et al., 2016. 
 
Injury induced Ca2+ wave is a cell signaling phenomenon when within 
milliseconds to seconds after injury, the binding of extracellular ATP to purinoreceptors 
triggers the release of intracellular stores of Ca2+. This event is used by cells to transduce 
mechanical signals into chemical signals as well as alter cell signaling pathways (Lee et 
al., 2019). P2X7 does not influence the distance and rate of Ca2+ wave propagation from 
the site of injury (Klepeis et al., 2001; Boucher et al., 2010; Minns et al., 2016). 




release of Ca2+. Reduction in the calcium signaling intensity following the injury can 
have a cascade of effects, further attenuating downstream signaling events and 
compromising the wound healing processes (Minns et al., 2016). 
Ca2+ wave promotes cytoskeletal rearrangement and cell migration. It was also 
linked to focal adhesions formation through the mechanosensory receptors (Kobayashi 
and Sokabe, 2010). Focal adhesion proteins are responsible for the cell movement and 
linkage of the cellular actin cytoskeleton to the underlying matrix (Mitra, Hanson, and 
Schlaepfer, 2005). The phosphorylation of focal adhesion proteins is Ca2+ dependent 
(Trinkaus-Randall, Kewalramani, Payne, and Cornell-Bell, 2000), and P2X7 dependent 
Ca2+ signaling is required for focal adhesion formation and migration (Henríquez et al., 
2011).    
  
FIGURE 20: P2X7 inactivation leads to a reduced amount of focal adhesions. 
Vinculin is a protein present in focal adhesion proteins, and in oxATP treated cells, 
it is localized only at the leading edge of the wound. In contrast, in control, it is 
prominent at the leading edge and in between cells. Note extensive filopodia present 
in the control condition, which are absent in oxATP treated cells. Adapted from 





Cell tracking diagram of inhibited P2X7 (Fig 17 B) illustrate a lack of coherent 
movement towards the wound's direction. Taken together with the role of P2X7, it could 
be speculated that this protein ion channel is vital in the mechanism of repairing the 
injury. It appears that disruption of P2X7 has a multi-pronged effect on HCLE cells by 
diminishing cell-cell communication and their ability to close the wound margin (Lee et 
al., 2019). A438079 treated HCLE cells have demonstrated an inability to move towards 
the wound, attenuation of an injury-induced Ca2+ wave (Minns et al., 2016), and reduced 
number of focal adhesions, while the focal adhesion lifespan is increased. Also, an 
overall decrease in membrane ruffling and thick actin bundles have been observed 
throughout imaging studies (Fig 14) which usually turn over in favor of shorter, thinner, 
and more oblique actin bundles (Minns et al., 2016). Stehbens and Wittman (2014) have 
also reported that increased focal adhesion splitting and merging events could be 
correlated to the disruption of focal adhesion disassembly, which could correlate with the 
reason why A438079 treated cells appear to lose the ability to move in the direction of 
the wound. When taken together, these findings shine a light on the overall migratory role 
P2X7 plays in response to corneal injury. Its ability to modulate Ca2+ signaling is 
correlated with the cell's ability to rearrange its actin cytoskeleton rearrangement at the 
leading edge.  
P2Y receptor family and P2Y2 
The P2Y receptors belong to a family of GPCR (G-protein coupled receptors). 
They primarily couple to Gαq and activate phospholipase C-β which triggers an increase 




1998). Phospholipase C, in turn, mediates PIP2 hydrolysis and activates the IP3 pathway, 
which leads to the sustained Ca2+ release via the opening of specific store-operated 
voltage-independent Ca2+ channels of the plasma membrane. This mechanism allows 
Ca2+ to enter the cell from the extracellular space (Lewis, 1999). 
 The P2Y receptors have been implicated in the regulation of cell migration, 
proliferation, and inflammation (Abbracchio and Burnstock, 1998; Burnstock, 1997; 
Neary et al., 1999). Furthermore, the P2Y2 receptor is also capable of activating Src, 
leading to the formation of the Grb/Shc complex, which phosphorylates and activates 
ERK (Soltoff et al., 1998). Phosphorylation of ERK is decreased when the P2Y2 receptor 
is being downregulated following siRNA treatment compared to control, which indicates 
that ERK phosphorylation depends on P2Y2 (Boucher et al., 2010). 
 
FIGURE 21: The P2Y2 receptor downregulation. Downregulation of P2Y2 inhibits 
nucleotide-induced Ca2+ wave release by 90% compared to control. siRNA was 
used to knock down the expression of P2Y2 and P2Y4, and maximal fluorescence 






Previous studies showed that inhibition of P2Y2 with siRNA against it has a 
detrimental effect on cell mobility (Boucher et al., 2010).  
 
FIGURE 22: P2Y2 mediates cell mobility. UTP is a nucleotide used to stimulate cell 
motility and wound closure. Non-targeting siRNA was used in control conditions, 
and anti P2Y2 siRNA was used in experimental conditions. (A) Control UTP treated 
and control untreated display higher percent wound closure when compared with 
P2Y2 siRNA UTP treated and P2Y2 siRNA UTP untreated condition, respectively. 
(B) The statistically significant difference in percent wound closure of control UTP 
treated vs. P2Y2 UTP treated and control UTP untreated vs. P2Y2 siRNA UTP 
untreated. (C) Cell migration also displays the statistically significant difference 





Experimental results obtained in this thesis (Fig 17 C) are complementary to 
figure 22. Effects of disrupting bulk healing shown in figure 22 are supported by the 
study of the receptors' role and their effect on individual cell movement conducted during 
this thesis. Usage of a competitive inhibitor of P2Y2, AR-C 118925XX, resulted in 
severe dysregulation of a coordinated cell movement towards the wound's direction. Cells 
closest to the injury site appear to rely on extracellular sources of Ca2+ for injury-
induced Ca2+ release (Boucher et al., 2010). Ca2+ also has a role in promoting 
cytoskeletal rearrangement and formation of adhesion structures, including 
hemidesmosomes, which are not detected if Ca2+ release is disrupted (Trinkaus-Randall 
and Gipson, 1984). It is also interesting to note that the disruption of cellular movement 
following the inhibition of P2Y2 is not limited to corneal cells. Wang et al. described that 
following transfection with anti P2Y2 receptor siRNA, migration was inhibited in 
astrocytes, cells that become activated in response to brain injury (Wang et al., 2005). 
Concluding Remarks 
 Results obtained experimentally for this thesis have demonstrated an altered cell 
movement profile when P2X7 and P2Y2 receptors were inhibited by their respective 
competitive inhibitors. Although the receptor profile of diabetic cells is currently 
unknown, the abnormal movement trajectories these cells display when viewed compared 
to the data obtained through imaging of HCLE cells in control and inhibitor conditions 





Previous studies showed that diabetic human corneas display elevated levels of 
P2X7 mRNA (Mankus et al., 2011), while studies conducted on the diabetic murine 
model showed altered localization of P2X7 (Kneer et al., 2016). These discoveries lead 
us to believe that there is a potential inverse relationship between P2X7 and P2Y2 
receptors. The upregulation of one receptor results in the downregulation of another, 
which is essential for healthy function. This inverse relationship is potentially altered for 
patients with type II diabetes, where P2X7 is upregulated and we speculate that it may 
not drop down far enough during the healing process compared to P2Y2, resulting in an 
altered cellular movement pattern, which affects the wound healing. 
Future studies will be needed to determine what receptors and in what fashion 
have been changed by the etiology of type II diabetes. One potential area of interest is to 
determine the precise nature of the relationship between P2X7 and P2Y2. There is a 
possibility of discovering an optimal interaction ratio of these two purinoreceptors 
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